Entries by jpop

Combatting Stigma against Buprenorphine

On July 19th, 2021, the Providence Journal published an article about a “Suboxone smuggling scheme” in Wyatt Detention Facility in Central Falls, RI. In response, Drs. Josiah Rich and Rosemarie Martin detail how this type of reporting perpetuates stigma surrounding MOUD as well as the benefits of buprenorphine for those with OUD. Learn more →

Andraka-Christou, B., Gabriel, M., Madeira, J., & Silverman, R. D. (2019). Court personnel attitudes towards medication-assisted treatment: A state-wide survey. J Subst Abuse Treat, 104, 72-82. doi:10.1016/j.jsat.2019.06.011 This article provides insight into the attitudes of justice professionals on MOUD treatment for the justice involved population. Study participants were employees in the state court and criminal […]

Peeler, M., Fiscella, K., Terplan, M., & Sufrin, C. (2019). Best Practices for Pregnant Incarcerated Women With Opioid Use Disorder. J Correct Health Care, 25(1), 4-14. doi:10.1177/1078345818819855 This article provides recommended strategies to optimize the care of pregnant incarcerated women with OUD, emphasizing the importance of appropriate counseling and treatment with opioid agonist pharmacotherapy.

Finlay, A. K., Harris, A. H., Rosenthal, J., Blue-Howells, J., Clark, S., McGuire, J., . . . Binswanger, I. (2016). Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug Alcohol Depend, 160, 222-226. doi:10.1016/j.drugalcdep.2016.01.013 This retrospective cohort study of veterans with an opioid use disorder diagnosis examined receipt of […]

Macmadu, A., Goedel, W. C., Adams, J. W., Brinkley-Rubinstein, L., Green, T. C., Clarke, J. G., . . . Marshall, B. D. L. (2020). Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails. Drug Alcohol Depend, 208, 107858. doi:10.1016/j.drugalcdep.2020.107858 The objective of this article […]

Friedmann, P. D., Hoskinson, R., Gordon, M., Schwartz, R., Kinlock, T., Knight, K., . . . Mat Working Group Of, C. J. D. (2012). Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions. Subst Abus, 33(1), 9-18. doi:10.1080/08897077.2011.611460 This article presents a study that surveyed […]

Binswanger, I. A. (2019). Opioid Use Disorder and Incarceration – Hope for Ensuring the Continuity of Treatment. N Engl J Med, 380(13), 1193-1195. doi:10.1056/NEJMp1900069 In this journal article, Dr. Ingrid A. Binswanger provides insight into her experience as a provider managing MOUD for justice involved populations and the risks of mandatory withdrawal upon entry into […]

Aronowitz, S. V., & Laurent, J. (2016). Screaming Behind a Door: The Experiences of Individuals Incarcerated Without Medication-Assisted Treatment. J Correct Health Care, 22(2), 98-108. doi:10.1177/1078345816634079 This dissertation by Shoshana Aronowitz highlights the experiences of withdrawal and being tapered from opioid treatment upon incarceration. She reports that being withheld from opioid treatment is an extremely […]

Gordon, M. S., Vocci, F. J., Fitzgerald, T. T., O’Grady, K. E., & O’Brien, C. P. (2017). Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment. Contemp Clin Trials, 53, 130-136. doi:10.1016/j.cct.2016.12.015 This article describes the design of a randomized controlled trial (RCT) that utilizes the combination of two interventions to address […]

McMillan, G. P., Lapham, S., & Lackey, M. (2008). The effect of a jail methadone maintenance therapy (MMT) program on inmate recidivism. Addiction, 103(12), 2017-2023. doi:10.1111/j.1360-0443.2008.02361.x This article described a prospective, longitudinal, observational study that evaluates the effects of a jail-based continuation of methadone maintenance therapy (MMT) on subsequent inmate recidivism risks. The authors found […]